Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187355 · ClinicalTrials.gov registry record · NA
Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers
A NA study of Symptomatic Contact Lens Wearers, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 591
- Enrollment target
- 1
- Study location
NCT01187355: Completed NA study of Symptomatic Contact Lens Wearers, sponsored by Alcon Research.
NCT01187355 is a NA study of Symptomatic Contact Lens Wearers that has completed, run by Alcon Research. The registered enrollment target is 591 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01187355, a NA study of Symptomatic Contact Lens Wearers, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 591 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two contact lens care solutions in symptomatic wearers of silicone hydrogel contact lenses.
Primary Outcome
As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.
Conditions Studied
Interventions
- DEVICE FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
- DEVICE renu fresh Multi-Purpose Solution (MPS)
- DEVICE Contact lenses
Study Locations (1)
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 591 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT01187355 record still lists
NCT01187355 is an interventional study that assigns participants to a tested intervention. The registered 591 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Symptomatic Contact Lens Wearers appearing as the primary indexed condition, and to 3 interventions - of which FID 114675A Multi-Purpose Disinfecting Solution (MPDS) is the first listed.
NCT01187355 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01187355 about?
NCT01187355 is a clinical study titled "Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers". The purpose of this study is to compare two contact lens care solutions in symptomatic wearers of silicone hydrogel contact lenses.
What is the current status of trial NCT01187355?
This trial is currently completed. It is a NA study. The enrollment target is 591 participants. The study started on 2010-07. Estimated completion is 2011-01.
What conditions does trial NCT01187355 study?
This clinical trial studies the following conditions: Symptomatic Contact Lens Wearers.
What interventions are being tested in trial NCT01187355?
The interventions under investigation include: FID 114675A Multi-Purpose Disinfecting Solution (MPDS) (DEVICE), renu fresh Multi-Purpose Solution (MPS) (DEVICE), Contact lenses (DEVICE).
Who is sponsoring clinical trial NCT01187355?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01187355 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01187355's enrollment target sits among peer trials
591 175th of 2000 higher than 1,826 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
- NCT04747626 · 590 participants · NA
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
- NCT05722938 · 590 participants · Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia